PNC Financial Services Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,375
| Closed | -$33.1K | – | 4891 |
|
|
2023
Q1 | $33.1K | Sell |
1,375
-1,250
| -48% | -$30.1K | ﹤0.01% | 3208 |
|
|
2022
Q4 | $27.7K | Buy |
2,625
+2,000
| +320% | +$21.1K | ﹤0.01% | 3306 |
|
|
2022
Q3 | $3K | Hold |
625
| – | – | ﹤0.01% | 4131 |
|
|
2022
Q2 | $3K | Hold |
625
| – | – | ﹤0.01% | 4150 |
|
|
2022
Q1 | $5K | Sell |
625
-70
| -10% | -$560 | ﹤0.01% | 4024 |
|
|
2021
Q4 | $4K | Sell |
695
-2,000
| -74% | -$11.5K | ﹤0.01% | 4049 |
|
|
2021
Q3 | $17K | Sell |
2,695
-189
| -7% | -$1.19K | ﹤0.01% | 3583 |
|
|
2021
Q2 | $24K | Buy |
2,884
+659
| +30% | +$5.48K | ﹤0.01% | 3400 |
|
|
2021
Q1 | $23K | Hold |
2,225
| – | – | ﹤0.01% | 3360 |
|
|
2020
Q4 | $38K | Hold |
2,225
| – | – | ﹤0.01% | 3062 |
|
|
2020
Q3 | $29K | Hold |
2,225
| – | – | ﹤0.01% | 3047 |
|
|
2020
Q2 | $31K | Buy |
2,225
+2,025
| +1,013% | +$28.2K | ﹤0.01% | 3007 |
|
|
2020
Q1 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 3769 |
|